Immuneering announces clinical supply agreement with Regeneron
Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...
Immuneering Signs Clinical Supply Agreement With Regeneron To Evaluate IMM-1-104 Plus Libtayo
Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
FiercePharma3h
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $1,000.00 Price Target at Bernstein Bank
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lowered by equities researchers at Bernstein Bank from $1,070.00 to $1,000.00 in a research note issued to investors on ...
Major CT company rolls out new logo in age of smartphone communication. It’s name is changing too.
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
Global Airway Clearance Devices for Cystic Fibrosis Market to Show Positive Growth at a CAGR of ~5% by 2032 | DelveInsight
DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...
TMCnet8h
W. Capra Announces Unified Company Under One New Brand
Today, W. Capra announced that the recently acquired Impact 21 business will be operating fully as W. Capra and unveiled a new company brand to reflect the change.